Results 61 to 70 of about 372,177 (293)

IGF2 knockout reduces but does not abolish osteosarcoma growth in vitro and in vivo

open access: yesFEBS Open Bio, EarlyView.
To test whether endogenous IGF2 promotes osteosarcoma growth, IGF2 was knocked out in Saos2 cells via CRISPR‐Cas9. KO cells showed reduced proliferation in vitro, and knockout xenografts in mice reached only ~25% of wild‐type tumor volume. Insulin‐like growth factor 2 (IGF2) is implicated in osteosarcoma, but direct functional evidence of its role is ...
Shun Yao, Marco Archetti
wiley   +1 more source

What Should Being to Prevent of Pain, Ecchymosis and Hematoma in Subcutaneous Heparin Injections?

open access: yesFlorence Nightingale Journal of Nursing, 2019
Today, subcutaneous heparin injections are commonly used for a variety of treatments. After the subcutaneous heparin injections, ecchymosis, hematoma occurence and pain are the most common complications.
Gülçin AVŞAR, Mağfiret KAŞIKÇI
doaj  

Análise da lipoenxertia estruturada na redefinição do contorno facial

open access: yesRevista Brasileira de Cirurgia Plástica
INTRODUÇÃO: A enxertia de gordura como preenchimento no rejuvenescimento e melhoria do contorno facial vem sendo usada por alguns autores e demonstra um potencial excelente como método de escolha para essa finalidade, uma vez que tem como premissa o ...
Marco Túlio Junqueira Amarante
doaj   +1 more source

Evidence and information for national injection safety policies [PDF]

open access: yes, 2003
The adverse consequences of poor injection practices have been reported for a few decades. However, key elements of evidence and information were lacking to allow decision-makers to formulate policies for the safe and appropriate use of injections.
Hutin, Yvan
core   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan   +5 more
wiley   +1 more source

Subcutaneous Injections of Saline Solution [PDF]

open access: yesThe American Journal of the Medical Sciences, 1898
n ...
openaire   +2 more sources

Energetic electron precipitation during sawtooth injections [PDF]

open access: yes, 2007
International audienceWe present simultaneous riometer observations of cosmic noise absorption in the nightside and dawn-noon sectors during sawtooth particle injections during 18 April 2002.
Donovan, E. F.   +13 more
core   +2 more sources

Incidence, Risk Factors and Management of Adverse Events in Contemporary Real‐World Care of Children with Juvenile Idiopathic Arthritis

open access: yesArthritis Care &Research, Accepted Article.
Objective We describe the frequency, risk factors, severity, and management of actionable and serious adverse events (AAE and SAE) in children with newly diagnosed Juvenile Idiopathic Arthritis (JIA) in Canada. Methods We enrolled patients within 3 months of JIA diagnosis in the Canadian Alliance of Pediatric Rheumatology Investigators (CAPRI) Registry,
Bashayer Alnuaimi   +10 more
wiley   +1 more source

Clinical Evaluation of an Investigational 5 mL Wearable Injector in Healthy Human Subjects

open access: yesClinical and Translational Science, 2021
An investigational wearable injector (WI), the BD Libertas Wearable Injector (BD Libertas is a trademark of Becton, Dickinson and Company), was evaluated in an early feasibility clinical study for functional performance, tissue effects, subject ...
Wendy D. Woodley   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy